Skip to content

Clinical trials

Metabolic Diseases trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Israel Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20161
20182
20191
20203
20221
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
89bio, Inc.2
Alnylam Pharmaceuticals1
AstraZeneca1
Hadassah Medical Organization1
Hillel Yaffe Medical Center1
Rabin Medical Center1
Rambam Health Care Campus1
Rezolute1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases15
Diabetes Mellitus, Type 27
Glucose Metabolism Disorders7
Diabetes Mellitus6
Endocrine System Diseases5
Digestive System Diseases3
Fatty Liver2
Fibrosis2
Kidney Diseases2
Liver Diseases2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.